MRAM
Everspin Technologies, Inc.
Semiconductors
Market Cap$503M
5Y Perf.+266.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MRAM vs IMOS
Revenue, margins, valuation, and 5-year total return — side by side.
IMOS
ChipMOS TECHNOLOGIES Inc.
Semiconductors
Market Cap$1.93B
5Y Perf.+172.6%
MRAM vs IMOS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MRAM | IMOS |
|---|---|---|
| Industry | Semiconductors | Semiconductors |
| Market Cap | $503M | $1.93B |
| Revenue (TTM) | $57M | $22.81B |
| Net Income (TTM) | $284K | $247M |
| Gross Margin | 51.5% | 9.5% |
| Operating Margin | -12.8% | 2.7% |
| Forward P/E | 862.4x | 0.7x |
| Total Debt | $3M | $15.16B |
| Cash & Equiv. | $44M | $15.22B |
MRAM vs IMOS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MRAM
IMOS
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Everspin Technologi… (MRAM) | 100 | 366.0 | +266.0% |
| ChipMOS TECHNOLOGIE… (IMOS) | 100 | 272.6 | +172.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRAM vs IMOS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: IMOS leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Everspin Technologies, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
MRAM
Everspin Technologies, Inc.
The Growth Play
MRAM is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 9.5%, EPS growth -173.9%, 3Y rev CAGR -2.7%
- Lower volatility, beta 2.85, Low D/E 4.8%, current ratio 4.84x
- 9.5% revenue growth vs IMOS's 6.3%
Best for: growth exposure and sleep-well-at-night
IMOS
ChipMOS TECHNOLOGIES Inc.
The Income Pick
IMOS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 1.36, yield 2.0%
- 276.2% 10Y total return vs MRAM's 168.8%
- Beta 1.36, yield 2.0%, current ratio 2.71x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MRAM | 9.5% revenue growth vs IMOS's 6.3% |
| Value | IMOS | Lower P/E (0.7x vs 862.4x) |
| Quality / Margins | IMOS | 1.1% margin vs MRAM's 0.5% |
| Stability / Safety | IMOS | Beta 1.36 vs MRAM's 2.85 |
| Dividends | IMOS | 2.0% yield; the other pay no meaningful dividend |
| Momentum (1Y) | MRAM | +278.9% vs IMOS's +224.3% |
| Efficiency (ROA) | IMOS | 0.6% ROA vs MRAM's 0.3%, ROIC 3.6% vs -18.4% |
MRAM vs IMOS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
MRAM vs IMOS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLIMOSLAGGINGMRAM
MRAMEverspin Technologies…
1leads
IMOSChipMOS TECHNOLOGIES …
3leads
6 Total Categories
CATEGORYLEADERvs MRAMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
IMOS4/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
IMOS6/8
Total Returns1Y, 3Y, 5Y total returns with dividends
MRAM5/6
Risk & VolatilityBeta, volatility, and downside exposure
IMOS2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Evenly matched — MRAM and IMOS each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IMOS is the larger business by revenue, generating $22.8B annually — 400.7x MRAM's $57M. Profitability is closely matched — net margins range from 1.1% (IMOS) to 0.5% (MRAM). On growth, MRAM holds the edge at +13.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MRAMEverspin Technolo… | IMOSChipMOS TECHNOLOG… |
|---|---|---|
| RevenueTrailing 12 months | $57M | $22.8B |
| EBITDAEarnings before interest/tax | -$4M | $5.6B |
| Net IncomeAfter-tax profit | $284,000 | $247M |
| Free Cash FlowCash after capex | -$1M | -$85M |
| Gross MarginGross profit ÷ Revenue | +51.5% | +9.5% |
| Operating MarginEBIT ÷ Revenue | -12.8% | +2.7% |
| Net MarginNet income ÷ Revenue | +0.5% | +1.1% |
| FCF MarginFCF ÷ Revenue | -2.1% | -0.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.2% | +1.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +74.4% | +22.0% |
Evenly matched — MRAM and IMOS each lead in 3 of 6 comparable metrics.
Valuation Metrics
IMOS leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
| Metric | MRAMEverspin Technolo… | IMOSChipMOS TECHNOLOG… |
|---|---|---|
| Market CapShares × price | $503M | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $462M | $1.9B |
| Trailing P/EPrice ÷ TTM EPS | -829.23x | 45.29x |
| Forward P/EPrice ÷ next-FY EPS est. | 862.40x | 0.75x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.72x |
| EV / EBITDAEnterprise value multiple | — | 9.91x |
| Price / SalesMarket cap ÷ Revenue | 9.11x | 2.68x |
| Price / BookPrice ÷ Book value/share | 7.06x | 2.57x |
| Price / FCFMarket cap ÷ FCF | 161.05x | 70.73x |
IMOS leads this category, winning 4 of 5 comparable metrics.
Profitability & Efficiency
IMOS leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
IMOS delivers a 1.1% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $0 for MRAM. MRAM carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to IMOS's 0.61x. On the Piotroski fundamental quality scale (0–9), IMOS scores 6/9 vs MRAM's 4/9, reflecting solid financial health.
| Metric | MRAMEverspin Technolo… | IMOSChipMOS TECHNOLOG… |
|---|---|---|
| ROE (TTM)Return on equity | +0.4% | +1.1% |
| ROA (TTM)Return on assets | +0.3% | +0.6% |
| ROICReturn on invested capital | -18.4% | +3.6% |
| ROCEReturn on capital employed | -9.4% | +3.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.05x | 0.61x |
| Net DebtTotal debt minus cash | -$41M | -$63M |
| Cash & Equiv.Liquid assets | $44M | $15.2B |
| Total DebtShort + long-term debt | $3M | $15.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 6.24x |
IMOS leads this category, winning 6 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
MRAM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MRAM five years ago would be worth $44,362 today (with dividends reinvested), compared to $19,363 for IMOS. Over the past 12 months, MRAM leads with a +278.9% total return vs IMOS's +224.3%. The 3-year compound annual growth rate (CAGR) favors MRAM at 43.6% vs IMOS's 32.2% — a key indicator of consistent wealth creation.
| Metric | MRAMEverspin Technolo… | IMOSChipMOS TECHNOLOG… |
|---|---|---|
| YTD ReturnYear-to-date | +114.3% | +81.7% |
| 1-Year ReturnPast 12 months | +278.9% | +224.3% |
| 3-Year ReturnCumulative with dividends | +196.2% | +131.1% |
| 5-Year ReturnCumulative with dividends | +343.6% | +93.6% |
| 10-Year ReturnCumulative with dividends | +168.8% | +276.2% |
| CAGR (3Y)Annualised 3-year return | +43.6% | +32.2% |
MRAM leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
IMOS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IMOS is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than MRAM's 2.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | MRAMEverspin Technolo… | IMOSChipMOS TECHNOLOG… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.85x | 1.36x |
| 52-Week HighHighest price in past year | $22.69 | $57.37 |
| 52-Week LowLowest price in past year | $5.49 | $15.06 |
| % of 52W HighCurrent price vs 52-week peak | +95.0% | +96.7% |
| RSI (14)Momentum oscillator 0–100 | 70.6 | 69.8 |
| Avg Volume (50D)Average daily shares traded | 994K | 63K |
IMOS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MRAM as "Buy" and IMOS as "Hold". IMOS is the only dividend payer here at 2.04% yield — a key consideration for income-focused portfolios.
| Metric | MRAMEverspin Technolo… | IMOSChipMOS TECHNOLOG… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $9.00 | — |
| # AnalystsCovering analysts | 5 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $35.67 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
IMOS leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). MRAM leads in 1 (Total Returns). 1 tied.
Best OverallChipMOS TECHNOLOGIES Inc. (IMOS)Leads 3 of 6 categories
Loading custom metrics...
MRAM vs IMOS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MRAM or IMOS a better buy right now?
For growth investors, Everspin Technologies, Inc.
(MRAM) is the stronger pick with 9. 5% revenue growth year-over-year, versus 6. 3% for ChipMOS TECHNOLOGIES Inc. (IMOS). ChipMOS TECHNOLOGIES Inc. (IMOS) offers the better valuation at 45. 3x trailing P/E (0. 7x forward), making it the more compelling value choice. Analysts rate Everspin Technologies, Inc. (MRAM) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRAM or IMOS?
On forward P/E, ChipMOS TECHNOLOGIES Inc.
is actually cheaper at 0. 7x.
03Which is the better long-term investment — MRAM or IMOS?
Over the past 5 years, Everspin Technologies, Inc.
(MRAM) delivered a total return of +343. 6%, compared to +93. 6% for ChipMOS TECHNOLOGIES Inc. (IMOS). Over 10 years, the gap is even starker: IMOS returned +276. 2% versus MRAM's +168. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRAM or IMOS?
By beta (market sensitivity over 5 years), ChipMOS TECHNOLOGIES Inc.
(IMOS) is the lower-risk stock at 1. 36β versus Everspin Technologies, Inc. 's 2. 85β — meaning MRAM is approximately 111% more volatile than IMOS relative to the S&P 500. On balance sheet safety, Everspin Technologies, Inc. (MRAM) carries a lower debt/equity ratio of 5% versus 61% for ChipMOS TECHNOLOGIES Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MRAM or IMOS?
By revenue growth (latest reported year), Everspin Technologies, Inc.
(MRAM) is pulling ahead at 9. 5% versus 6. 3% for ChipMOS TECHNOLOGIES Inc. (IMOS). On earnings-per-share growth, the picture is similar: ChipMOS TECHNOLOGIES Inc. grew EPS -25. 2% year-over-year, compared to -173. 9% for Everspin Technologies, Inc.. Over a 3-year CAGR, MRAM leads at -2. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRAM or IMOS?
ChipMOS TECHNOLOGIES Inc.
(IMOS) is the more profitable company, earning 6. 3% net margin versus -1. 1% for Everspin Technologies, Inc. — meaning it keeps 6. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IMOS leads at 5. 6% versus -11. 8% for MRAM. At the gross margin level — before operating expenses — MRAM leads at 51. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MRAM or IMOS more undervalued right now?
On forward earnings alone, ChipMOS TECHNOLOGIES Inc.
(IMOS) trades at 0. 7x forward P/E versus 862. 4x for Everspin Technologies, Inc. — 861. 7x cheaper on a one-year earnings basis.
08Which pays a better dividend — MRAM or IMOS?
In this comparison, IMOS (2.
0% yield) pays a dividend. MRAM does not pay a meaningful dividend and should not be held primarily for income.
09Is MRAM or IMOS better for a retirement portfolio?
For long-horizon retirement investors, ChipMOS TECHNOLOGIES Inc.
(IMOS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2. 0% yield, +276. 2% 10Y return). Everspin Technologies, Inc. (MRAM) carries a higher beta of 2. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IMOS: +276. 2%, MRAM: +168. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MRAM and IMOS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
IMOS pays a dividend while MRAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(MRAM: 13.2% · IMOS: 1.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.